A detailed history of Bessemer Group Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 243,558 shares of RVMD stock, worth $10.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
243,558
Previous 243,442 0.05%
Holding current value
$10.5 Million
Previous $9.45 Million 16.9%
% of portfolio
0.02%
Previous 0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$36.92 - $47.94 $4,282 - $5,561
116 Added 0.05%
243,558 $11 Million
Q3 2023

Nov 13, 2023

SELL
$25.17 - $35.05 $5.01 Million - $6.97 Million
-199,000 Reduced 44.98%
243,442 $6.74 Million
Q1 2023

May 10, 2023

SELL
$20.76 - $30.09 $634,446 - $919,580
-30,561 Reduced 6.46%
442,442 $9.58 Million
Q4 2022

Feb 13, 2023

SELL
$17.68 - $25.53 $68,014 - $98,213
-3,847 Reduced 0.81%
473,003 $11.3 Million
Q3 2022

Nov 09, 2022

BUY
$17.46 - $26.0 $677,378 - $1.01 Million
38,796 Added 8.86%
476,850 $9.4 Million
Q1 2021

May 13, 2021

SELL
$37.21 - $54.43 $4.21 Million - $6.16 Million
-113,197 Reduced 20.53%
438,054 $20.1 Million
Q4 2020

Feb 09, 2021

SELL
$30.19 - $45.49 $3.75 Million - $5.65 Million
-124,167 Reduced 18.38%
551,251 $21.8 Million
Q1 2020

Apr 30, 2020

BUY
$20.0 - $34.08 $13.5 Million - $23 Million
675,418 New
675,418 $14.8 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.